N/A N=12 Effect of Pneumatic Tourniquet on Arm Swelling After Lymph Node Removal
Healthy Subject
Primary: Change in Hand Volume Following Tourniquet Use — 15.0; 12.1; 12.5; 7.9 mL
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=31 Supportive Programs for Supporting Optimal Recovery in Participants Undergoing Gynecological Surgery
Ovarian Neoplasm · Uterine Neoplasm
Primary: Percentage of Participants Retained in the Study — 78.6; 82.4 percentage of participants retained
N/A N=77 Bright Light Therapy for Treatment of Sleep Problems Following Mild Traumatic Brain Injury
Concussion, Mild · Post-Concussion Symptoms · Sleep Problems
Primary: Sleep Quality - Pittsburgh Sleep Quality Index (PSQI) — 1.28; 1.35 score on a scale
Phase 4 N=356 Addressing Racial/Ethnic Tobacco Health Disparities Via Group Intervention
Smoking Cessation
Primary: The Number of Participants Reporting 7 Day Point Prevalence Abstinence — 54; 45 Participants
Phase 2 N=47 Efficacy of Bromocriptine For Fever Reduction in Acute Neurologic Injury
Subarachnoid Hemorrhage · Subdural Hematoma · Traumatic Brain Injury
Primary: Temperature Burden — 37.8; 37.7 Temperature in degrees Celsius
Phase 4 N=24 Study for the Treatment of Transfusional Iron Overload in Myelodysplastic Patients
Myelodysplastic Syndromes · Iron Overload
Primary: Number of Participants With Adverse Events and Serious Adverse Events — 24; 11 Participants
Phase 2 N=29 Pharmacokinetic Study of Oral Testosterone (T) Ester Formulations in Hypogonadal Men
Hypogonadism
Primary: Serum Testosterone Average Concentration (Cavg) (ng/dL) — 792; 654; 541; 765 ng/dL
Phase 2 N=41 RTA 408 Capsules in Patients With Melanoma - REVEAL
Melanoma · Unresectable (Stage III) Melanoma · Metastatic (Stage IV) Melanoma
Primary: Measure of Efficacy of the Phase 2 Dose of RTA 408 in Combination With Nivolumab Using Overall Response Rate (ORR; Complete Plus Partial Responses) According to RECIST…
Phase 2 N=18 CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma
Acute Myeloid Leukemia · B-Cell Non-Hodgkin Lymphoma · Chronic Lymphocytic Leukemia
Primary: Full-dose Donor Chimerism (FDC) — 12 Participants
Phase 2 N=39 Safety and Tolerability of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing Spondylitis
Ankylosing Spondylitis
Primary: Number of Participants Reported Adverse Events (AE's) — 21; 6; 6; 3 Participants
N/A N=1,116 Developing and Assessing a Male Engagement Intervention in Option B+ in Malawi
Hiv
Primary: Number of Women Retained in Care — 160; 164 Participants
N/A N=451 Computerized Assessment and Referral System Screener for Mental Health Evaluations in the Emergency Setting
Mental Health
Primary: Number of Participants With CARS Mental Health Diagnoses Made in the ED; the Number of Psychiatry Evaluations in the Emergency Department (ED); and the Number of Mental…
Phase 4 N=22 Efficacy of Lisdexamfetamine Dimesylate for Promoting Occupational Success in Young Adults With ADHD
Attention Deficit Disorder With Hyperactivity
Primary: Ratings of Job Application Quality — 3.40; 3.56 score on a scale
Phase 2 N=151 Safety, Efficacy and Treatment Regimen Study of ST266 in Subjects With Moderate to Severe Periodontitis
Periodontal Disease
Primary: Changes in Pocket Depth (PD) for Those Pockets ≥ 6 mm at Baseline — 6.6; 6.6; 6.7; 4.5 Pocket Depth (mm) — p=0.341
N/A N=17 Dorsal Wrist Ganglia; Aspiration Alone vs Aspiration and Injection of Platelet Rich Plasma
Ganglion of Wrist
Primary: Number of Participants With a Recurrence of Ganglia — 8; 5 Participants